Table 7.
Lifetime attributable risk (LAR) for five patients
|
Organ |
Modality\ID |
LAR* |
||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
|
Lung |
IMRT |
4.1 |
3.3 |
6.9 |
220.4 |
18.0 |
| |
VMAT |
4.3 |
3.4 |
7.7 |
244.3 |
22.5 |
| |
TOMO |
56.4 |
72.6 |
89.6 |
277.9 |
135.3 |
|
Stomach |
IMRT |
27.4 |
46.5 |
34.7 |
73.0 |
102.9 |
| |
VMAT |
27.5 |
46.9 |
34.7 |
73.0 |
165.1 |
| |
TOMO |
27.5 |
47.3 |
34.7 |
73.0 |
79.5 |
|
Normal liver |
IMRT |
18.5 |
24.2 |
22.1 |
17.2 |
34.4 |
| |
VMAT |
18.5 |
24.1 |
22.2 |
17.9 |
35.5 |
| |
TOMO |
19.5 |
28.7 |
23.4 |
18.8 |
17.8 |
|
Small intestine |
IMRT |
14.5 |
9.5 |
23.9 |
58.4 |
15.1 |
| |
VMAT |
13.6 |
10.6 |
24.4 |
58.1 |
21.6 |
| |
TOMO |
15.0 |
7.7 |
23.8 |
100.5 |
12.6 |
|
Prostate/Ovary |
IMRT |
0.2 |
0.2 |
0.2 |
7.4 |
2.5 |
| |
VMAT |
0.1 |
0.1 |
0.2 |
6.0 |
2.4 |
| |
TOMO |
0.2 |
0.1 |
0.2 |
5.5 |
2.0 |
|
Rectum |
IMRT |
3.8 |
2.8 |
5.9 |
14.6 |
4.4 |
| |
VMAT |
3.1 |
2.3 |
4.9 |
11.7 |
4.5 |
| TOMO | 3.7 | 2.3 | 4.5 | 11.5 | 3.6 | |
*LAR: per 10000 persons.